Lab21 makes molecular diagnostics deal with US oncology research centre
This article was originally published in Clinica
Executive Summary
Lab21 has agreed to provide molecular diagnostic support services to the new Institute for Translational Oncology Research (ITOR) in Greenville, South Carolina. The centre is moving into the personalised cancer therapy sector and aims to translate lab research into practical applications for patients. It is part of the Greenville University Hospital System University Medical Center. Lab21 hopes the deal will help it identify and develop new biomarker panels through interactions with cancer physicians at ITOR. Last year, the Cambridge, UK-based firm set up a US subsidiary, Lab21 Inc, in Greenville (www.clinica.co.uk, 23 December 2009). It says the potential relationship with ITOR was one of the reasons it chose the site.